First Look: Heally and MediCann Announce Partnership

As Jeff Sessions, U.S. Attorney General, moves towards a reversal of policy implemented under the Obama administration, cloud-based telehealth platform Heally announced that they will be providing MediCann, one of the largest medical cannabis clinical intermediaries in California, their tele-medicine platform for all clinical consultations as well as partnering together on scientific research and data collection programs to increase efficacy in patient recommendations.

If you’re not familiar with Heally, it’s a peer-to-peer cloud-based telehealth platform that allows patients to instantly be matched with a doctor and leverages proprietary data to deliver the most effective cannabis products to meet each patient’s needs.

MediCann was founded by Dr. Jean Talleyrand in 2004 and is one of the longest running medical cannabis intermediaries, connecting patients with clinical groups and offering medical cannabis evaluation and education. While MediCann clinics are primarily located in the Bay area of California, MediCann patients will now be able connect with their preferred physician from anywhere through their private patient portal, eliminating geographical barriers and delivering personalized care in the privacy of their own homes or offices. The partnership also directs patients post-consultation to recommended medicines available at local dispensaries.

We’re told that the Heally and MediCann’s partnership will also leverage “The Dosing Project” to increase efficacy in recommended patient treatments.

“Heally offers recommendations for medicinal marijuana from certified doctors that is personal to you through your own private patient portal while MediCann is the leading clinical group in this space – one that is also leading scientific research studies into health and efficacy,” said Greg Rovner, CEO, Heally. “By sharing our expertise, the partnership will offer patients personal, private engagement with leading physicians and leverage expert data and scientific research to achieve better patient outcomes. I cannot think of a more innovative, exciting partnership,” he continued.

This post was written by:

- who has written 626 posts on mHealthWatch.

Contact the author